Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

NCT04245839

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Local Institution - 111 Santa Monica, California, United States
  • Local Institution - 107 Aurora, Colorado, United States
  • Local Institution - 105 New Haven, Connecticut, United States
  • Local Institution - 103 Chicago, Illinois, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

NCT05574114

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

NCT03383094

Conditions
Cancer, Cancer of Head and Neck, Cancer, Advanced, +35 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • H. Lee Moffitt Cancer Center & Research Facility Tampa, Florida, United States
  • Washington University School of Medicine, Siteman Cancer Center St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

NCT05104775

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +11 more
Locations
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Active, Not Recruiting

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

NCT05634707

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, Recurrent, +18 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • NYU Langone Health New York, United States
  • The Preston Robert Tisch Brain Tumor Center at Duke University Durham, North Carolina, United States
View Trial Details
Active, Not Recruiting

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

NCT06245915

Conditions
Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa and Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details

Related conditions